What type of study is this?

This is a Literature Review study.

Flow cytometric and molecular MRD in AML: current methods, clinical applications and challenges

View Full Paper

Ask AI

Bookmark

Authors

Review reveals prognostic value of measurable residual disease in AML treatment, highlighting new methodologies and clinical applications.

Measurable residual disease improves prognostic information in acute myeloid leukemia management.
Methods like flow cytometry and next-generation sequencing enhance treatment strategies for AML patients.
Clinical applications of MRD support decision-making in stem cell transplantation and treatment intensity.
Standardization of MRD methods is crucial for enhancing accuracy and reliability across laboratories.

Haaksma et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Review reveals prognostic value of measurable residual disease in AML treatment, highlighting new methodologies and clinical applications.